Performance of high-risk human papillomavirus DNA testing as a primary screen for cervical cancer: a pooled analysis of individual patient data from 17 population-based studies from China
View abstract on PubMed
Summary
This summary is machine-generated.High-risk human papillomavirus (HPV) DNA testing shows high sensitivity for detecting cervical cancer precursors (CIN grade 3 or worse) in China. Adjusting the HPV DNA test cutoff may improve screening effectiveness, especially for younger women.
Area Of Science
- Oncology
- Gynecology
- Public Health
Background
- Debate exists regarding the utility of high-risk human papillomavirus (HPV) DNA testing as a primary cervical cancer screening method.
- The study aimed to evaluate HPV DNA testing for cervical cancer screening in China and similar developing nations.
Purpose Of The Study
- To assess the applicability of HPV DNA testing in cervical cancer screening programs in China and comparable developing countries.
- To determine the diagnostic accuracy of HPV DNA testing for detecting cervical intraepithelial neoplasia grade 3 or greater.
Main Methods
- Pooled analysis of 17 population-based cervical cancer screening studies in China (1999-2008).
- Concurrent HPV DNA testing (Hybrid Capture 2), liquid-based cytology (LBC), and visual inspection with acetic acid (VIA) were used.
- Diagnostic accuracy was assessed for HPV DNA testing against CIN grade 3 or greater, confirmed by biopsy.
Main Results
- HPV DNA testing demonstrated high sensitivity (97.5%) but moderate specificity (85.1%) for CIN grade 3 or worse, outperforming cytology and VIA in sensitivity.
- Specificity varied with age, being highest in women under 35.
- Increasing the HPV DNA test cutoff from 1 pg/mL to 2 pg/mL reduced positivity but slightly lowered sensitivity; a cutoff of 10 pg/mL in women under 35 maintained high sensitivity and improved specificity.
Conclusions
- HPV DNA testing is a highly sensitive and moderately specific tool for detecting CIN grade 3 or worse, with consistent performance across diverse populations and age groups.
- Adjusting the HPV DNA test cutoff point, particularly for younger women, may enhance the efficiency of future cervical cancer screening programs in China.